Nikkei 225

Index

N225

JP9010C00002

Market Closed - 02:25:00 2024-05-01 am EDT 5-day change 1st Jan Change
38,274 PTS -0.34% Intraday chart for Nikkei 225 -0.48% +14.37%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Japan Industrial Production Up 3.8% in March on Month, Off 6.7% on Year MT
FTSE 100 shakes off New York slump before Fed AN
U.S. Futures Decline, Most European Markets Closed DJ
KDDI Completes Tender Offer for Lawson MT
Starts Proceed Investment Bags Energy-Efficiency Certification for Chiba Property MT
GSK ups outlook; Next first-quarter beats forecast AN
Japanese Shares Slip Into Red Ahead of US Fed Rate Decision; Tamron Falls 10% MT
Tamron Ups Fiscal H1 Targets as Q1 Attributable Profit, Net Sales Grow; Shares Surge 9% MT
Chudenko Returns to Profit in Fiscal 2024 on Improved Net Sales MT
FTSE 100 to tread water; Fed decision ahead AN
Financial Partners' Attributable Profit Climbs 53% in Fiscal H1 MT
Japan's Manufacturing PMI Revised Lower in April MT
Japan's Nikkei edges lower as investors await Fed decision RE
Murata Manufacturing to Allocate Treasury Shares Worth Up to 300 Million Yen as Restricted Stock Compensation MT
Murata Manufacturing to Buy Back Up to 2.3% of Outstanding Shares MT
Murata Manufacturing's Fiscal 2023 Attributable Profit Misses Forecast, Revenue Beats MT
SMS' Attributable Profit Climbs 13% in Fiscal 2023 on Higher Net Sales MT
Shikoku Electric Power Returns to Profit in Fiscal 2023 Amid Lower Spending MT
Seiko Epson's Board OKs Up to 30 Billion Yen Share Buyback MT
Nordic Shares Moved Upward Tuesday; Hoegh Autoliners Topped Leaders DJ
Avant Group to Form JV with Cygnet Infotech to Enter Indian Software Market MT
Wall Street, Earnings, Federal Reserve Roil Asian Stock Markets MT
Commerzbank on Overnight News MT
Europeans down after inflation and Eurozone GDP. AN
SocGen's Overnight Economic News Summary MT
  1. Stock Market
  2. Indexes
  3. Nikkei 225
  4. News Nikkei 225
  5. Nikkei 225 : Gains 0.4%, Extends Gains on COVID-19 Vaccine Outlook